Personalis Inc PSNL:NASDAQ

Last Price$3.68NASDAQ Previous Close - Last Trade as of 4:00PM ET 6/28/22

Today's Change-0.23(5.88%)
Bid (Size)$3.10 (1)
Ask (Size)$5.12 (2)
Day Low / High$3.64 - 4.05
Volume538.5 K

Evaxion Biotech to Use Personalis Platform to Evaluate Efficacy of Skin Cancer Combination Therapy

10:56AM ET 4/26/2022 MT Newswires
Evaxion Biotech (EVAX) will use Personalis's (PSNL) ImmunoID NeXT platform in a phase 2b trial to assess the efficacy and safety of its EVX-01 personalized cancer immunotherapy, the companies said Tuesday.

The study will combine EVX-01 with Keytruda, or pembrolizumab, to treat late-stage metastatic melanoma, a type of skin cancer, according to the companies.

Evaxion shares were down 1% in recent trading, while Personalis was 4% lower.

Price: 3.04, Change: +0.07, Percent Change: -1.00